Skip to content

Drug interactions

Encorafenib + Indacaterol

Severity: Moderate

Encorafenib and Indacaterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encorafenib can prolong the QT interval in a dose-related manner. Indacaterol may add QT and heart rate effects and lower potassium. The combination may raise arrhythmia risk in susceptible patients.

What this interaction means in plain words

Encorafenib and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Encorafenib belongs to Oncology; Indacaterol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive QT prolongation.

What to do

Monitor ECG and electrolytes, and correct hypokalemia or hypomagnesemia before and during treatment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Indacaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encorafenib with Indacaterol?

MediHelp rates the interaction as moderate. Encorafenib and Indacaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib can prolong the QT interval in a dose-related manner. Indacaterol may add QT and heart rate effects and lower potassium. The combination may raise arrhythmia risk in susceptible patients.

How serious is the interaction between Encorafenib and Indacaterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes, and correct hypokalemia or hypomagnesemia before and during treatment.

What other medicines interact with Indacaterol?

MediHelp also lists interactions of Indacaterol with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Indacaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in